You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

"Cardiovascular disease (CVD) is the number one
cause of death worldwide with an estimated 17.5 million deaths each year,
representing 30 % of all deaths."[1]

Do you know the different ECLS/ECMO therapy options?

Many CVD patients experience cardiogenic shock, a frequent consequence of a heart attack, because the heart muscle is not adequately supplied with oxygen. Other conditions that can lead to failure of the heart and/or lungs include acute respiratory distress syndrome (ARDS), severe influenza (e.g., H1N1), septic shock and pulmonary embolism. Patients with serious cardiac and/or pulmonary compromise require immediate stabilization and perhaps inter-hospital transfer.

Extracorporeal life support (ECLS), or extracorporeal membrane oxygenation (ECMO), has become a standard therapy option to stabilize blood circulation and/or respiratory functions of affected patients.

ECLS therapy to prevent organ damage

ECLS or ECMO can be used to temporarily support heart and/or lung function (partially or totally) during cardiopulmonary failure, leading to organ recovery or replacement. Veno-arterial life support is used with patients whose hearts are not adequately supporting their circulation or have arrested, which may occur with a myocardial infarction. Veno-venous life support provides respiratory assistance for lung disorders, and is primarily used when the heart is still able to pump blood through the circulatory system without any additional support.

Reduction of blood CO₂

Facilitating protective ventilation strategies, even in severe cases of acute respiratory failure

The veno-venous use of the CARDIOHELP System ensures an effective oxygen supply and/or the reduction of blood CO2 level in intensive care patients suffering from ARDS, sepsis or other indications associated with acute respiratory failure.


Did you know that ECLS could be a life saver for ARDS patients?

Severe acute respiratory distress syndrome (ARDS) continues to have still has a high mortality rate. Extracorporeal life support (ECLS) can be a good therapy option when standard therapies fail. The use of ECLS for adult ARDS has increased over the last decade. More and more specialized centers use perform ECLS today, and there are many reports available that confirm that ECLS therapies deliver improved outcomes for adult ARDS patients.

With its CARDIOHELP System, Getinge makes available a portable heart-lung support system providing mechanical extracorporeal assist to replace or support a patient's blood circulation and/or gas exchange. 

All references

  1. 1. World Health Organization, Global status report on non-communicable diseases 2014.